Join Dr. Tina Korownyk for an in-depth discussion about the management of Alzheimer’s Disease. Learn about new interventions such as aducanumab and donanemab which stirred controversy in the medical community when approved by the FDA. Review the current evidence for pharmacological treatment of Alzheimer’s Disease and learn about the limitations of observational data and the…